Biological and Thrombolytic Properties of Proenzyme and Active Forms of Human Urokinase – II. Turnover of Natural and Recombinant Urokinase in Rabbits and Squirrel Monkeys
- 1 January 1984
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 52 (01) , 024-026
- https://doi.org/10.1055/s-0038-1661128
Abstract
The turnover of recombinant pro-urokinase (Rec-pro-UK), recombinant urokinase (Rec-UK) and natural urinary urokinase (Nat-UK) was studied in rabbits and in squirrel monkeys (Samiri sciureus). Following intravenous injection, urokinase activity disappeared rapidly from the blood. The initial disappearance rate could be described by a single exponential term with a t½ of 3 to 6 min for each molecular form of urokinase in both species. Urokinase related antigen, measured with a radioimmunoassay in the plasma of the squirrel monkeys disappeared with a t½ of 3.5 min for Rec-pro-UK, 6.0 min for Rec-UK and 8.0 min for Nat-UK. The clearance and organ distribution of Rec-pro-UK, Rec-UK and Nat-UK was studied with the use of 125I-labeled preparations. In each case the radioactivity initially disappeared rapidly from the plasma, also with a t½ of a few min, but then the disappearance rate slowed down. Labeled Rec-UK in which the active site histidine was irreversibly blocked by alkylation, disappeared equally rapidly from the plasma. Measurement of the organ distribution of 125I at different time intervals revealed that all three types of urokinase were rapidly accumulated in the liver, which was followed by release of degradation products in the blood. Experimental hepatectomy prolonged the t½ of each type of urokinase very markedly (t½ >30 min). These findings indicate that urokinase is rapidly removed from the blood by clearance and degradation in the liver. Recognition by the liver does not require a functional active site and is not mediated via carbohydrate side chains. Inactivation by plasma protease inhibitors does not represent a significant pathway of urokinase inhibition in vivo.Keywords
This publication has 11 references indexed in Scilit:
- Ligand binding, conformational change and plasma elimination of human, mouse and rat α-macroglobulin proteinase inhibitorsBiochemical Journal, 1983
- The in vivo metabolism of antithrombin III and antithrombin III complexes.Journal of Biological Chemistry, 1982
- Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.Journal of Biological Chemistry, 1981
- IMMUNOCHEMICAL CHARACTERIZATION OF THE PLASMIN-ANTIPLASMIN SYSTEM - BASIS FOR THE SPECIFIC DETECTION OF THE PLASMIN-ANTIPLASMIN COMPLEX BY LATEX AGGLUTINATION ASSAYS1979
- TURNOVER OF ANTI-PLASMIN, THE FAST-ACTING PLASMIN INHIBITOR OF PLASMA1979
- Hepatic receptor that specifically binds oligosaccharides containing fucosyl α1→3 N -acetylglucosamine linkagesProceedings of the National Academy of Sciences, 1978
- Isolation and characterization of a mannan-binding protein from rabbit liverBiochemical and Biophysical Research Communications, 1978
- Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages.Proceedings of the National Academy of Sciences, 1978
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT . MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION1965